Severe histamine mediated reactions to intravenous drugs used in anaesthesia.
Severe histamine mediated reactions to intravenous drugs used in anaesthesia may occur as a result of anaphylactic and anaphylactoid reactions. The incidence is rare, but appears to be increasing. The difficulties in diagnosing such reactions and in determining the drug responsible and how these difficulties have led to confusion in the literature are discussed. Six cases of severe histamine mediated reactions are presented and detailed analyses of the drugs in these and other reported reactions is made showing varied clinical patterns with different drugs. The prevention, treatment, and follow-up of severe histamine mediated reactions are considered.
D000293:Adolescent; D000328:Adult; D000530:Alfaxalone Alfadolone Mixture / Q000009:adverse effects; D000707:Anaphylaxis / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D000771:Anesthesia, Intravenous / Q000009:adverse effects*; D000777:Anesthetics / Q000009:adverse effects*; D000937:Antigen-Antibody Reactions; D004342:Drug Hypersensitivity / Q000209:etiology*; D005188:False Negative Reactions; D005189:False Positive Reactions; D005260:Female; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006636:Histamine Release; D006801:Humans; D008297:Male; D003473:Neuromuscular Nondepolarizing Agents / Q000009:adverse effects; D011410:Propanidid / Q000009:adverse effects; D012882:Skin Tests; D013390:Succinylcholine / Q000009:adverse effects; D013874:Thiopental / Q000009:adverse effects
D000777:Anesthetics; D006634:Histamine H1 Antagonists; D003473:Neuromuscular Nondepolarizing Agents; D000530:Alfaxalone Alfadolone Mixture; D011410:Propanidid; D013390:Succinylcholine; D013874:Thiopental